Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC) (original) (raw)

Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study

Angela Spanu

Diagnostics, 2021

View PDFchevron_right

Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?

anu bhattarai

View PDFchevron_right

2-[18F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study

Alberto Miceli

Diagnostics, 2022

View PDFchevron_right

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy

Michele Klain

Medicine, 2017

View PDFchevron_right

18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer

James Mountz

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007

View PDFchevron_right

IMAGING IN ENDOCRINOLOGY: 18F-FDG PET/CT in differentiated thyroid carcinoma: clinical indications and controversies in the diagnosis and follow- up of differentiated thyroid cancer

Bernadette Biondi

European journal of endocrinology / European Federation of Endocrine Societies, 2015

View PDFchevron_right

The Added Clinical Value of 18F-FDG PET/CT in Evaluating Intratracheal Recurrence of Differentiated Thyroid Carcinoma: Implications for Planning Surgery, Assessing Its Completeness, and Planning Radioiodine Therapy

Amit Abhyankar

Journal of Nuclear Medicine Technology, 2013

View PDFchevron_right

Dose-response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT

Felix Mottaghy

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016

View PDFchevron_right

Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?

Francesco Giammarile

European Journal of Endocrinology, 2003

View PDFchevron_right

Low FDG Metabolic Activity of Loco-Regional Recurrence in Thyroid Cancer Patients; Is Iodine-131 has a Potentiality?

Esraa Ahmed

The Open Nuclear Medicine Journal, 2014

View PDFchevron_right

Diagnostic Management of Suspected Metastatic Thyroid Carcinoma. A Comparative study of Octreotide, dedicated and non-dedicated PET FDG Scans in Patients with Negative High Dose Radioiodine Scan

Francesco Giammarile

View PDFchevron_right

FDG PET Performed at Thyroid Remnant Ablation Has a Higher Predictive Value for Long-Term Survival of High-Risk Patients With Well-Differentiated Thyroid Cancer Than Radioiodine Uptake

Nagara Tamaki

Clinical nuclear medicine, 2015

View PDFchevron_right

PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?

Richard Kloos

Arquivos Brasileiros de Endocrinologia & Metabologia, 2007

View PDFchevron_right

Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer

Carlo Cavaliere

European Journal of Nuclear Medicine and Molecular Imaging, 2020

View PDFchevron_right

IMAGING IN ENDOCRINOLOGY: 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up

Bernadette Biondi

European journal of endocrinology, 2015

View PDFchevron_right

Head-to-head comparison of F-18 FDG PET/CT in radioidine refractory thyroid cancer patients with elevated versus suppressed TSH levels a pilot study

Santiago Almeida

Heliyon, 2020

View PDFchevron_right

18F-FDG PET/CT in Differentiated Thyroid Carcinoma

D. Piciu

Acta Endocrinologica (Bucharest), 2019

View PDFchevron_right

Early Predictive Response to Multi-Tyrosine Kinase Inhibitors in Advanced Refractory Radioactive-Iodine Differentiated Thyroid Cancer: A New Challenge for [18F]FDG PET/CT

Giulia Santo

Diagnostics

View PDFchevron_right

[18F]-2-Fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and …

Steven Larson

Journal of Clinical …, 1999

View PDFchevron_right

Prognostic Value of FDG PET/CT in Differentiated Thyroid Cancer Patients

khaled elsaban

The Egyptian Journal of Hospital Medicine

View PDFchevron_right

Prognostic Role of 2-[18F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative 131I WBS and Positive 2-[18F]-FDG PET/CT

Carlo Rodella

Diagnostics

View PDFchevron_right

18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study

Giovanni Frezza

Journal of thyroid research, 2017

View PDFchevron_right

FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma

Seo Young Kang

PLOS ONE

View PDFchevron_right

Assessment of lesion response in the initial radioiodine treatment of differentiated thyroid cancer using 124I PET imaging

Walter Jentzen

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014

View PDFchevron_right

Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET

Andreas Bockisch

European Journal of Nuclear Medicine and Molecular Imaging, 2008

View PDFchevron_right

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[ 18 F]Fluoro-2-Deoxy- d -Glucose-Positron Emission Tomography Scanning

Steven Larson

The Journal of Clinical Endocrinology & Metabolism, 2006

View PDFchevron_right

Histopathologic Characterization of Radioactive Iodine-Refractory Fluorodeoxyglucose-Positron Emission Tomography-Positive Thyroid Carcinoma

Daniel Gomez

Cancer, 2008

View PDFchevron_right

18F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study

Fabio Orlandi

European Journal of Nuclear Medicine and Molecular Imaging, 2014

View PDFchevron_right

Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study

Laura Terry

BMC Cancer, 2014

View PDFchevron_right

Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hürthle Cell Thyroid Cancer Patients

Heiko Schoder

Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2006

View PDFchevron_right

Role of 18F-FDG PET and PET/CT imaging in thyroid cancer

Stefano Fanti

Biomedicine & Pharmacotherapy, 2006

View PDFchevron_right

Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma

R. Görges

Annals of Surgery, 2001

View PDFchevron_right